U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.641C>G (p.Ala214Gly) AND MECP2-related disorder

Germline classification:
Likely benign (1 submission)
Last evaluated:
May 12, 2024
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004735945.1

Allele description [Variation Report for NM_001110792.2(MECP2):c.641C>G (p.Ala214Gly)]

NM_001110792.2(MECP2):c.641C>G (p.Ala214Gly)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.641C>G (p.Ala214Gly)
HGVS:
  • NC_000023.11:g.154031223G>C
  • NG_007107.3:g.110881C>G
  • NM_001110792.2:c.641C>GMANE SELECT
  • NM_001316337.2:c.326C>G
  • NM_001369391.2:c.326C>G
  • NM_001369392.2:c.326C>G
  • NM_001369393.2:c.326C>G
  • NM_001369394.2:c.326C>G
  • NM_001386137.1:c.-65C>G
  • NM_001386138.1:c.-65C>G
  • NM_001386139.1:c.-65C>G
  • NM_004992.4:c.605C>G
  • NP_001104262.1:p.Ala214Gly
  • NP_001303266.1:p.Ala109Gly
  • NP_001356320.1:p.Ala109Gly
  • NP_001356321.1:p.Ala109Gly
  • NP_001356322.1:p.Ala109Gly
  • NP_001356323.1:p.Ala109Gly
  • NP_004983.1:p.Ala202Gly
  • NP_004983.1:p.Ala202Gly
  • LRG_764t1:c.641C>G
  • LRG_764t2:c.605C>G
  • LRG_764:g.110881C>G
  • LRG_764p1:p.Ala214Gly
  • LRG_764p2:p.Ala202Gly
  • NC_000023.10:g.153296674G>C
  • NG_007107.2:g.110905C>G
  • NM_004992.3:c.605C>G
Protein change:
A109G
Links:
dbSNP: rs587783138
NCBI 1000 Genomes Browser:
rs587783138
Molecular consequence:
  • NM_001386137.1:c.-65C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386138.1:c.-65C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386139.1:c.-65C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001110792.2:c.641C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.326C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.326C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.326C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.326C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.326C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.605C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
MECP2-related disorder
Synonyms:
MECP2-related condition; MECP2-related disorders
Identifiers:
MedGen: C5880921

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV005364171PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Likely benign
(May 12, 2024) 		germlineclinical testing

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV005364171.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024